TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARMP

Armata Pharmaceuticals Inc

Healthcare · Biotechnology

4.20$ +2.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Armata Pharmaceuticals Inc (ARMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -26 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARMP
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-13 -9.8 -11 -9.2 -9.4 -16 -18 -24 -32 -47 -38 -26
0.2 0.3 0.4 0.4 0.4 1.4 1.1 1.2 0.9 1.0 1.3 1.5
1.9 0.5 2.0 0.7 0.5 4.3 3.5 2.9 3.1 0.9 2.9 2.6
0.3 5.2 4.7 3.7 3.4 3.9
-0.6 -0.2 0.7 -0.5 0.3 -2.2 -0.9 -3.2 0.4 -9.6 -2.1 -1.4
1.2 0.2 0.3 0.1 0.0 0.1 0.8 1.3 2.2 8.1 1.9 0.5
-1.2 -0.2 -0.3 -0.1 0.0 2.9 -0.8 -1.3 -2.2 -8.1 -1.9 -0.5
0.1 0.0
13 -0.2 9.5 12 10.0 23 27 45 0.0
0.7 0.7 0.7 0.7 0.0 -0.5 54 35 25
13 7.2 8.7 12 9.0 23 26 44 54 35 26
-14 2.8 -3.7 -0.6 3.0 -3.7 4.1 0.6 4.6 -1.6 -4.5 -0.7
-14 -10.0 -11 -9.3 -9.4 -16 -19 -25 -35 -56 -39 -26

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?